Peptide design of NPM-1–derived peptides for CD4⁺ and/or CD8⁺ T-cell induction assays. Several HLA-DRB1–binding motifs derived from either intact or mutated NPM1 sequences were predicted for their specific binding capacity using the SYFPEITHI program.